These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 14660711

  • 1. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y.
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [Abstract] [Full Text] [Related]

  • 2. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H, Yamauchi H, Sugimoto K, Takahashi M.
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [Abstract] [Full Text] [Related]

  • 3. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Fukumura T, Masuda K, Fujii K, Fukui M.
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [Abstract] [Full Text] [Related]

  • 4. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
    Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M.
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1349-56. PubMed ID: 12271418
    [Abstract] [Full Text] [Related]

  • 5. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
    Kuroda S, Shiga T, Ishikawa T, Houkin K, Narita T, Katoh C, Tamaki N, Iwasaki Y.
    J Nucl Med; 2004 Jun; 45(6):943-9. PubMed ID: 15181128
    [Abstract] [Full Text] [Related]

  • 6. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
    Weber B, Westera G, Treyer V, Burger C, Khan N, Buck A.
    J Nucl Med; 2004 Aug; 45(8):1344-50. PubMed ID: 15299060
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.
    Isozaki M, Arai Y, Kudo T, Kiyono Y, Kobayashi M, Kubota T, Kikuta K, Okazawa H.
    Ann Nucl Med; 2010 Jun; 24(5):371-7. PubMed ID: 20238185
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H, Ogasawara K, Suzuki T, Chida K, Aso K, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Kubo Y, Ogawa A.
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [Abstract] [Full Text] [Related]

  • 11. Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate.
    Treyer V, Jobin M, Burger C, Teneggi V, Buck A.
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):572-80. PubMed ID: 12552334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers.
    Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M.
    J Cereb Blood Flow Metab; 2001 Dec; 21(12):1472-9. PubMed ID: 11740209
    [Abstract] [Full Text] [Related]

  • 14. Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study.
    Yata K, Suzuki A, Hatazawa J, Shimosegawa E, Nagata K, Sato M, Moroi J.
    Stroke; 2006 Feb; 37(2):534-6. PubMed ID: 16410481
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of time dependency of the acetazolamide effect on cerebral hemodynamics as measured by 99mTc-ECD single-photon emission computed tomography].
    Takaki A, Mizuta Y, Murakami M, Yonehara T, Urata J, Okada K, Takaki R, Hirano T, Fujioka S.
    Kaku Igaku; 2001 Jan; 38(1):31-8. PubMed ID: 11257761
    [Abstract] [Full Text] [Related]

  • 16. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H, Tsuchida T, Kobayashi M, Arai Y, Pagani M, Isozaki M, Yonekura Y.
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine.
    Nishizawa S, Iida H, Tsuchida T, Ito H, Konishi J, Yonekura Y.
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):943-50. PubMed ID: 12734690
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.